JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

B1445 Flunixin Meglumin

Target: COX

Summary: potent cyclooxygenase inhibitor

≥24.55 mg/mL
B1455 Tolfenamic Acid

Summary: Non-steroidal anti-inflammatory drug

insoluble in H2O; ≥13.09 mg/mL
B1340 Naphazoline HCl

Summary: Adrenergic receptor agonist
B1899 Bromhexine HCl

Summary: bronchial mucolytic agent
B2182 CAY10505

Summary: Potent PI3Kγ inhibitor

insoluble in EtOH; insoluble in H2O; ≥14.45 mg/mL
B1964 Lonidamine

Target: Hexokinases

Summary: hexokinase inactivator

insoluble in H2O; insoluble in EtOH; 50 mg/mL
B2272 Phenytoin sodium

Target: Voltage-gated Sodium (NaV) Channels

Summary: Sodium channel stabilizer

insoluble in H2O; insoluble in EtOH; ≥11.55 mg/mL
B2271 Phenytoin

Summary: inactive voltage-gated sodium channel stabilizer

insoluble in H2O; ≥11 mg/mL
B1998 Oxfendazole

Summary: broad spectrum benzimidazole anthelmintic

insoluble in EtOH; insoluble in H2O; ≥15.75 mg/mL
B2010 Pranoprofen

Summary: non-steroidal COX inhibitor

insoluble in H2O; ≥11.5 mg/mL